[Experience of joint administration of neuromidin and ovestin for correcting cognitive disorders in females with hypoestrogenic syndrome].
The aim of the present study was to assess the efficacy of combined administration of neuromidin and ovestin in low doses for pharmacocorrection of cognitive disorders in women after total ovariectomy. The obtained results are indicative of a pronounced efficacy of the proposed combined therapy for the pharmaco-correction of cognitive disorders as compared to the standard hormone replacement therapy in women with hypoestrogenic syndrome. This is confirmed by significant decrease of mental impairments on the conventional (Mattis dementia) clinical rating scale and in neuropsychological tests.